Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: david james who wrote (745)	3/10/2000 12:41:00 PM
From: Bosco	Read Replies (1) of 1298

Hi david & all - just completed my position. This money rotating out of biotech is a godsend. I am late to the game but never is too late Btw, did anyone catch Jessica Savage's commentary on NBR on 3/8/00 nightlybusiness.org The combined market cap of biotech is ~$280B [should have come down a lot by now <G>,] about twice that of MRK, but since biotech has just emerged from the dark age of trials and errors, with a lot more tools and rational approach, I think this sector is likely to make the B2B looks like nickel and dime play best, Bosco

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next